Page last updated: 2024-08-26

mizoribine and Sjogren's Syndrome

mizoribine has been researched along with Sjogren's Syndrome in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imadachi, S; Ito, M; Iwanaga, N; Izumi, Y; Kamata, M; Kurohama, H; Migita, K; Nakaoka, K1
Fujimoto, T; Nakamura, S; Nakayamada, S; Nonomura, A; Saito, K; Tanaka, Y1
Abe, T; Imai, K; Kimura, H; Matsumoto, S; Nishimura, S; Nojima, M; Oki, M; Sakai, H; Taga, M; Takahashi, H; Tanaka, H1
Iizuka, N; Kondo, H1
Hashimoto, N; Ito, S; Kondo, H; Mimori, T; Minota, S; Nakayamada, S; Nara, H; Ogawa, N; Okada, J; Saito, K; Sano, H; Sugai, S; Sumida, T; Tanaka, Y; Umehara, H; Yoshifuji, H1

Reviews

2 review(s) available for mizoribine and Sjogren's Syndrome

ArticleYear
[A case of rheumatoid arthritis/Sjogren's syndrome with acute renal failure due to hyperuricemia associated with mizoribine therapy].
    Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology, 2004, Volume: 27, Issue:3

    Topics: Acute Kidney Injury; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Drug Therapy, Combination; Etodolac; Female; Humans; Hyperuricemia; Middle Aged; Phenylacetates; Prednisolone; Ribonucleosides; Sjogren's Syndrome

2004
[Mizoribine].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 5

    Topics: Animals; Arthritis, Rheumatoid; Depression, Chemical; Guanosine Monophosphate; Humans; Immunosuppressive Agents; Lupus Nephritis; Lymphocyte Activation; Mice; Purines; Randomized Controlled Trials as Topic; Ribonucleosides; Sjogren's Syndrome; T-Lymphocytes

2005

Trials

2 trial(s) available for mizoribine and Sjogren's Syndrome

ArticleYear
Usefulness of initial histological features for stratifying Sjogren's syndrome responders to mizoribine therapy.
    Rheumatology (Oxford, England), 2009, Volume: 48, Issue:10

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Biopsy; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Ribonucleosides; Salivary Glands, Minor; Salivation; Sjogren's Syndrome; Treatment Outcome

2009
Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial.
    Modern rheumatology, 2007, Volume: 17, Issue:6

    Topics: Aged; Deglutition Disorders; Female; Humans; Immunosuppressive Agents; IMP Dehydrogenase; Male; Middle Aged; Ribonucleosides; Saliva; Salivation; Sjogren's Syndrome; Treatment Outcome; Xerophthalmia

2007

Other Studies

1 other study(ies) available for mizoribine and Sjogren's Syndrome

ArticleYear
Steroid-resistant protein-losing gastroenteropathy complicated with Sjögren's syndrome successfully treated with mizoribine.
    Modern rheumatology, 2018, Volume: 28, Issue:4

    Topics: Female; Glucocorticoids; Humans; Immunosuppressive Agents; Middle Aged; Prednisolone; Protein-Losing Enteropathies; Ribonucleosides; Sjogren's Syndrome

2018